Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Accounts Payable and Accrued Expenses (Tables)

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Dec. 31, 2021

Accrued Liabilities and other Long-Term Liabilities [Abstract]

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following:


		December 31,				December 31,
($ in thousands)		2021			2020
Accounts Payable		$	47,429		$	11,412
Accrued expenses:
Professional fees			1,835			1,236
Salaries, bonus and related benefits			8,809			6,701
Research and development			7,932			5,007
Research and development - manufacturing			—			518
Research and development - license maintenance fees			4,640			461
Research and development - milestones			850			600
Accrued royalties payable			3,833			2,682
Accrued coupon and rebates			10,603			12,869
Income taxes payable			—			136
Return reserve			3,240			2,580
Other			1,489			1,187
Total accounts payable and accrued expenses		$	90,660		$	45,389